Does Helicobater pylori infection play a role in extragastric diseases?;Existe-t-il des manifestations extradigestives de l'infection à Helicobacter pylori ?

Presse Medicale

Volumn 37, Issue 3 PART 2, 2008, Pages 525-534

  de Korwin, Jean Dominique ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GHRELIN; IMMUNOGLOBULIN;

ATHEROSCLEROSIS; DIGESTIVE SYSTEM DISEASE; DISEASE ASSOCIATION; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IRON DEFICIENCY ANEMIA; ISCHEMIC HEART DISEASE; LUNG DISEASE; NUTRITIONAL STATUS; PARKINSON DISEASE; RAYNAUD PHENOMENON; SHORT SURVEY; SKIN DISEASE; STOMACH DISEASE; URTICARIA; CARDIOVASCULAR DISEASE; HEMATOLOGIC DISEASE; REVIEW;

CARDIOVASCULAR DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEMATOLOGIC DISEASES; HUMANS;

EID: 41649107299     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.07.029     Document Type: Short Survey

References (89)

1. S. Suerbaum P. Michetti Helicobacter pylori infection N Engl J Med 347 2002 1175 1186
2. D.A. Israel R.M. Peek Jr. The role of persistence in Helicobacter pylori pathogenesis Curr Opin Gastroenterol 22 1 2006 3 7
3. De Korwin JD, Frédéric M. Les gastrites chroniques. EMC Gastro-entérologie 2003;9-017-A-10.
4. J.D. De Korwin La gastrite à Helicobacter pylori , une pathologie frontière Rev Med Interne 27 Suppl. 2 2006 S61 S63
5. K.J. Goodman S.L. Joyce K.P. Ismond Extragastric diseases associated with Helicobacter pylori infection Curr Gastroenterol Rep 8 6 2006 458 464
6. J.V. Solnick F. Franceschi D. Roccarina A. Gasbarrini Extragastric manifestations of Helicobacter pylori infection and other Helicobacter species Helicobacter 11 Suppl. 1 2006 46 51
7. H. Suzuki B.J. Marshall T. Hibi Overview: Helicobacter pylori and extragastric disease Int J Hematol 84 4 2006 291 300
8. M. Franchini D. Veneri Helicobacter pylori -associated immune thrombocytopenia Platelets 17 2 2006 71 77
9. S. Jackson P.L. Beck G.F. Pineo M.C. Poon Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature Am J Hematol 78 2 2005 142 150
10. K. Kohda T. Kuga K. Kogawa Y. Kanisawa K. Koike G. Kuroiwa Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura Br J Haematol 118 2 2002 584 588
11. K. Ando T. Shimamoto T. Tauchi Y. Ito Y. Kuriyama A. Gotoh Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review Int J Hematol 77 3 2003 239 244
12. S. Hashino A. Mori S. Suzuki K. Izumiyama K. Kahata M. Yonezumi Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori Int J Hematol 77 2 2003 188 191
13. M. Hino T. Yamane K. Park T. Takubo K. Ohta S. Kitagawa Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura Ann Hematol 82 1 2003 30 32
14. S. Hashino S. Ota S. Kobayashi J. Tanaka M. Musashi T. Fukuhara Current status of treatment for patients with idiopathic thrombocytopenic purpura in the Hokkaido area (evaluation of Helicobacter pylori eradication)] Rinsho Ketsueki 45 7 2004 539 545
15. A. Kato H. Kato N. Hirashima T. Sakamoto H. Nukaya K. Ito Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients Nippon Shokakibyo Gakkai Zasshi 101 11 2004 1209 1216
16. R. Sato K. Murakami K. Watanabe T. Okimoto H. Miyajima M. Ogata Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura Arch Intern Med 164 17 2004 1904 1907
17. T. Takahashi T. Yujiri K. Shinohara Y. Inoue Y. Sato Y. Fujii Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori -associated chronic idiopathic thrombocytopenic purpura Br J Haematol 124 1 2004 91 96
18. K. Fujimura Y. Kuwana Y. Kurata M. Imamura H. Harada H. Sakamaki Is eradication therapy useful as the first line of treatment in Helicobacter pylori- positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan Int J Hematol 81 2 2005 162 168
19. T. Inaba M. Mizuno S. Take K. Suwaki T. Honda K. Kawai Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan Eur J Clin Invest 35 3 2005 214 219
20. T. Suzuki M. Matsushima A. Masui K. Watanabe A. Takagi Y. Ogawa Effect of Helicobacter pylori eradication in patients with in chronic idiopathic thrombocytopenic purpura-a randomized controlled trial Am J Med 100 6 2005 1265 1270
21. M. Kodama Y. Kitadai M. Ito H. Kai H. Masuda S. Tanaka Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura Helicobacter 12 1 2007 36 42
22. A. Gasbarrini F. Franceschi R. Tartaglione R. Landolfi P. Pola G. Gasbarrini Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori Lancet 352 9131 1998 878
23. G. Emilia G. Longo M. Luppi G. Gandini M. Morselli L. Ferrara Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura Blood 97 3 2001 812 814
24. I. Jarque R. Andreu I. Llopis J. de la Rubia F. Gomis L. Senent Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura Br J Haematol 115 4 2001 1002 1003
25. M. Michel M. Khellaf L. Desforges K. Lee A. Schaeffer B. Godeau Autoimmune thrombocytopenic purpura and Helicobacter pylori infection Arch Intern Med 162 9 2002 1033 1036
26. D. Veneri M. Franchini M. Gottardi M. D’Adda A. Ambrosetti M. Krampera Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura Haematologica 87 11 2002 1177 1179
27. E. Kurtoglu E. Kayacetin A. Ugur Helicobacter pylori infection in patients with autoimmune thrombocytopenic purpura World J Gastroenterol 10 14 2004 2113 2115
28. M. Michel N. Cooper C. Jean C. Frissora J.B. Bussel Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 103 3 2004 890 896
29. R. Stasi Z. Rossi E. Stipa S. Amodori A.C. Newland D. Provan Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura Am J Med 118 4 2005 414 419
30. D. Veneri G. De Matteis P. Solero F. Federici C. Zanuso E. Guizzardi Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment Platelets 16 5 2005 307 311
31. D. Veneri M. Krampera M. Franchini High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: a long-term follow-up study Platelets 16 2 2005 117 119
32. N. Suvajdzic B. Stankovic V. Artiko T. Cvejic V. Bulat M. Bakrac Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura Platelets 17 4 2006 227 230
33. K.R. McCrae Helicobacter pylori and ITP: many questions, few answers Blood 103 3 2004 752 753
34. Y. Tsutsumi H. Kanamori H. Yamato N. Ehira T. Kawamura S. Umehara Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura Ann Hematol 84 12 2005 807 811
35. M. Ishiyama M. Teramura K. Iwabe T. Kato T. Motoji Clonally expanded T-cells in the peripheral blood of patients with idiopathic thrombocytopenic purpura and Helicobacter pylori infection Int J Hematol 83 2 2006 147 151
36. P. Malfertheiner F. Megraud C. O’Morain F. Bazzoli E. El-Omar D. Graham Current concepts in the management of Helicobacter pylori infection – The Maastricht III Consensus Report Gut 56 2007 772 781
37. W.D. Chey B.C.Y. Wong American College of Gastroenterology guideline on management of Helicobacter pylori infection Am J Gastroenterol 102 2007 1 18
38. S. DuBois D.J. Kearney Iron-deficiency anaemia and Helicobacter pylori infection: a review of the evidence Am J Gastroenterol 100 2005 453 459
39. V.M. Cardenas Z.D. Mulla M. Ortiz D.Y. Graham Iron deficiency and Helicobacter pylori infection in the United States Am J Epidemiol 163 2006 127 134
40. S. Nahon P. Lahmek J. Massard B. Lesgourgues N. Mariaud de Serre L. Traissac Helicobacter pylori-associated chronic gastritis and unexplained iron deficiency anemia: a reliable association? Helicobacter 8 6 2003 573 577
41. B. Annibale M. Marignani B. Monarca G. Antonelli A. Marcheggiano G. Martino Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis Ann Intern Med 131 9 1999 668 672
42. A. Hacihanefioglu F. Edebali A. Celebi T. Karakaya O. Senturk S. Hulagu Improvement of complete blood count in patients with iron deficiency anemia and Helicobacter pylori infection after the eradication of Helicobacter pylori Hepatogastroenterology 51 55 2004 313 315
43. C. Ciacci F. Sabbatini R. Cavallaro F. Castiglione S. Di Bella P. Iovino Helicobacter pylori impairs iron absorption in infected individuals Dig Liver Dis 36 2004 455 460
44. B. Wedi A. Kapp Helicobacter pylori infection in skin diseases: a critical appraisal Am J Clin Dermatol 3 4 2002 273 282
45. P. Gaig P. Garcia-Ortega E. Enrique M. Papo J.C. Quer C. Richard Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study Allergol Immunopathol 30 5 2002 255 258
46. D.G. Federman R.S. Kirsner J.P. Moriarty J. Concato The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria J Am Acad Dermatol 49 5 2003 861 864
47. A. Moreira J. Rodrigues L. Delgado J. Fonseca M. Vaz Is Helicobacter pylori infection associated with chronic idiopathic urticaria? Allergol Immunopathol 31 4 2003 209 214
48. S. Fukuda T. Shimoyama N. Umegaki T. Mikami H. Nakano A. Munakata Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria J Gastroenterol 39 9 2004 827 830
49. M. Sakurane A. Shiotani F. Furukawa Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori -positive Japanese patients J Dermatol 29 1 2002 23 27
50. I.H. Galadari M.O. Sheriff The role of Helicobacter pylori in urticaria and atopic dermatitis Skinmed 5 4 2006 172 176
51. H.L. Witherell K.L. Smith G.D. Friedman C. Ley D.H. Thom N. Orentreich C-reactive protein, Helicobacter pylori , Chlamydiae pneumoniae, cytomegalovirus and risk for myocardial infarction Ann Epidemiol 13 3 2003 170 177
52. P.M. Ridker J. Danesh L. Youngman R. Collins M.J. Stampfer R. Peto A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men Ann Intern Med 135 3 2001 184 188
53. F. Cremonini M. Gabrielli G. Gasbarrini P. Pola A. Gasbarrini The relationship between chronic H.pylori infection, CagA seropositivity and stroke: meta-analysis Atherosclerosis 173 2 2004 253 259
54. M.R. Preusch A.J. Grau F. Buggle C. Lichy J. Bartel C. Black Association between cerebral ischemia and cytotoxin-associated gene-A-bearing strains of Helicobacter pylori Stroke 35 8 2004 1800 1804
55. R.K. Singh A.D. McMahon H. Patel C.J. Packard B.J. Rathbone N.J. Samani Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease Heart 88 2002 43 46
56. P. Whincup J. Danesh M. Walker L. Lennon A. Thomson P. Appleby Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men Circulation 101 2000 1647 1652
57. A.F. Stone P. Risley H.S. Markus B.K. Butland D.P. Strachan P.C. Elwood Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study Heart 86 5 2001 506 509
58. M. Mayr S. Kiechl M.A. Mendall J. Willeit G. Wick Q. Xu Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study Stroke 34 3 2003 610 615
59. H.S. Markus P. Risley M.A. Mendall H. Steinmetz M. Sitzetr Helicobacter pylori infection, the cytotoxin gene A strain and carotid artery intima-media thickness J Cardiovasc Risk 9 1 2002 1 6
60. M. Diomedi A. Pietroiusti M. Silvestrini B. Rizzato L.M. Cupini F. Ferrante Cag-A-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke Neurology 63 5 2004 800 804
61. F.F. Mussa H. Chai X. Wang Q. Yao A.B. Lumsden C. Chen Chlamydiae pneumoniae and vascular disease: an update J Vasc Surg 43 6 2006 1301 1307
62. A.G. Fraser R.K. Scragg B. Cox R.T. Jackson Helicobacter pylori , Chlamydia pneumoniae and myocardial infarction Intern Med J 33 7 2003 267 272
63. B.D. Horne J.B. Muhlestein G.G. Strobel J.F. Carlquist T.L. Bair J.L. Anderson Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention Am Heart J 144 3 2002 491 500
64. P.J. Lindsberg A.J. Grau Inflammation and infections as risk factors for ischemic stroke Stroke 34 2003 2518 2532
65. M. Kanbay G. Gur M. Yucel U. Yilmaz S. Boyacioglu Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci 50 7 2005 1228 1231
66. M. Gabrielli A. Santoliquido F. Cremonini V. Cicconi M. Candelli M. Serricchio CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke Eur Heart J 25 2004 64 68
67. M.F. Byrne S.W. Kerrigan P.A. Corcoran J.C. Atherton F.E. Murray D.J. Fitzgerald Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation Gastroenterology 124 7 2003 1983 1985
68. C. Figueiredo J.C. Machado P. Pharoah R. Seruca S. Sousa R. Carvalho Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma J Natl Cancer Inst 94 22 2002 1662 1663
69. D.J. Lamb W. El-Sankary G.A. Ferns Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation Atherosclerosis 167 2 2003 177 185
70. F. Franceschi A.R. Sepulveda A. Gasbarrini P. Pola N. Gentiloni G. Gasbarrini Cross-reactivity of Anti-CagA antibodies with vascular wall antigens Circulation 106 2002 430 434
71. M. Kowalski M. Pawlik J.W. Konturek S.J. Konturek Helicobacter pylori infection in coronary artery disease J Physiol Pharmacol 57 suppl 3 2006 101 111
72. A.F. Stone M.A. Mendall J.C. Kaski T.M. Edger P. Risley J. Poloniecki Effect of treatment for Chlamydiae pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and unstable Angina (STAMINA) Circulation 106 10 2002 1219 1223
73. R. Andraw J.S. Berger D.L. Brown Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials JAMA 293 21 2005 2641 2647
74. H. Scharnagl M. Kist A.B. Grawitz W. Koenig H. Wieland W. Marz Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol Am J Cardiol 93 2 2004 219 220
75. A. Gasbarrini M. Serricchio P. Tondi G. Gasbarrini P. Pola Association of Helicobacter pylori infection with primary Raynaud phenomenon Lancet 348 9032 1996 966 967
76. V. Savarino A. Sulli P. Zentilin M. Raffaella Mele M. Cutolo No evidence of an association between Helicobacter pylori infection and Raynaud phenomenon Scand J Gastroenterol 35 12 2000 1251 1254
77. A. Sulli B. Seriolo V. Savarino M. Cutolo Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud's phenomenon in patients with systemic sclerosis J Rheumatol 27 7 2000 1820 1821
78. J.D. de Korwin S. Lopez X. Haristoy A. Lozniewski C. Schmidt Raynaud's phenomenon is not associated with Helicobacter pylori infection Gut 49 Suppl. II 2004 A202
79. F. Herve N. Cailleux Y. Benhamou P. Ducrotté J.F. Lemeland P. Denis Helicobacter pylori prevalence in Raynaud's disease Rev Med Interne 27 10 2006 736 741
80. A. Gasbarrini I. Massari M. Serricchio P. Tondi A. De Luca F. Francheschi Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon Dig Dis Sci 43 8 1998 1641 1645
81. M. Kanbay A. Kanbay S. Boyacioglu Helicobacter pylori infection as a possible risk factor for respiratory system disease/a review of the literature Respir Med 101 2 2007 203 209
82. I.T. Bjarnasson A. Charlett R.J. Dobbs S.M. Dobbs M.A. Ibrahim R.W. Kerwin Role of chronic infection and inflammation in the gastrointestinal tract in the aetiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebo-controlled efficacy study Helicobacter 10 4 2005 276 287
83. C. Weller A. Charlett N.L. Oxlade S.M. Dobbs R.H. Dobbs D.W. Peterson Role of chronic infection and inflammation in the gastrointestinal tract in the aetiology and pathogenesis of idiopathic parkinsonism. Part 3: predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile Helicobacter 10 4 2005 288 297
84. J.D. Schulz E.L. Hawkes C.A. Shaw Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denominator Med Hypotheses 66 6 2006 1222 1226 Epub 2006 Feb 20
85. M. Pierantozzi A. Pietroiusti L. Brusa S. Galati A. Stefani G. Lunardi Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations Neurology 66 12 2006 1824 1829
86. M. Centanni L. Gargano G. Canettieri N. Viceconti A. Franchi G. Delle Fave Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis N Engl J Med 354 2006 1787 1795
87. H. Isomoto H. Ueno V.A. Saenko M.S. Mondal Y. Nishi N. Kawano Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans Am J Gastroenterol 100 8 2005 1711 1720
88. A. Tatsuguchi K. Miyake K. Gudis S. Futagami T. Tsukui K. Wada Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa Am J Gastroenterol 99 11 2004 2121 2127
89. N. Salles A. Menard A. Georges M. Salzmann V. de Ledinghen A. de Mascarel Effects of Helicobacter pylori infection on gut appetite peptide (leptin, ghrelin) expression in elderly inpatients J Gerontol A Biol Sci Med Sci 61 11 2006 1144 1150